Kuldeep Singh Rajput

Kuldeep Singh Rajput is the CEO and Founder of Biofourmis, a fast-growing digital health company filled with committed, passionate people who care about augmenting personalized care and empowering people with complex chronic conditions to live better and healthier lives.

Recognized as the “Forbes 30 Under 30”, Kuldeep has demonstrated strong leadership experience with building teams, developing talents, and successfully growing, and managing strategic partnerships with global pharmaceutical manufacturers, health systems and Payers.

Under his leadership, Biofourmis has raised over US$45 Million in venture capital from leading Venture Capital firms including Sequoia Capital, MassMutual Ventures, Singapore Govt-linked EDBI, Aviva plc, and Mayo Clinic Ventures.

He uses his background and experience in biomedical engineering and data from the Massachusetts Institute of Technology (MIT) to unfold his vision of “Predicting and Preventing Serious Medical Events using AI”. During his Ph.D. studies at the National University of Singapore (NUS), he built bioelectronic implants, which aim to control biological processes and treat diseases by modulating electric impulses.